CLL is a frequent mature B-cell lymphoid neoplasm, where PI3K kinase is constitutively activated through BCR signaling [18], and may be an interesting tumor model to explore the possible clinical impact of ENDOG expression, either alone or in relation to PTEN status. Here, BCR is linked to B-cell chronic lymphocytic leukemia.